Protara Therapeutics, Inc. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
Protara Therapeutics, Inc. (TARA) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $1.11 million as of 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2021-03-11
- 2020-12-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $1.11M.
- 2020-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $82.91K.
- 2020-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $38.35K.
- 2020-03-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $53.74K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2020-12-31 | $1.11M 10-K · filed 2021-03-11 |
| 2020-09-30 | $82.91K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $38.35K 10-Q · filed 2020-07-31 |
| 2020-03-31 | $53.74K 10-Q · filed 2020-05-13 |
| 2018-09-30 | $69.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $138.00K 10-Q · filed 2018-08-07 |
| 2018-03-31 | $204.00K 10-Q · filed 2018-05-09 |
| 2017-09-30 | $44.00K 10-Q · filed 2017-11-07 |
| 2016-09-30 | $42.00K 10-Q · filed 2016-11-07 |
| 2016-06-30 | $84.00K 10-Q · filed 2016-08-08 |
| 2016-03-31 | $126.00K 10-Q · filed 2016-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |